Background There are several reports of extracorporeal membrane oxygenation (ECMO)
use in patients with coronavirus disease 2019 (COVID-19) who develop severe acute …

Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), represents the pandemic of the century, with …

Purpose Limited data are available on venovenous extracorporeal membrane oxygenation
(ECMO) in patients with severe hypoxemic respiratory failure from coronavirus disease 2019 …

Key Clinical Points Evaluation and Management of Severe Covid-19 Patients with severe
coronavirus disease 2019 (Covid-19) may become critically ill with acute respiratory distress …

Objective: To determine the outcomes of patients undergoing tracheostomy for COVID-19
and of healthcare workers performing these procedures. Background: Tracheostomy is often …

Traced back to December 2019, an unexpected outbreak of a highly contagious new
coronavirus pneumonia (COVID-19) has rapidly swept around China and the globe. There …

Background Coronavirus disease 2019 (COVID-19) remains a worldwide pandemic with a
high mortality rate among patients requiring mechanical ventilation. The limited data that …

Arising from the city of Wuhan, Hubei province in China, a novel coronavirus named severe
acute respiratory syndrome coronavirus 2 has been rapidly spreading since its first …

Objective We aimed to examine the literature evidence behind using extracorporeal
membrane oxygenation in COVID‐19 patients in a systematic review manner. Methods We …

Background Infection due to severe acute respiratory coronavirus 2 (SARS-CoV-2) may lead
to an atypical acute respiratory distress syndrome (ARDS)[1], requiring in the most severe …